Pharmaceutical Co-Crystallization: Regulatory Aspects, Design, Characterization, and Applications

Abdul Raheem Thayyil ¹ * , Thimmasetty Juturu ¹ , Shashank Nayak ¹ , Shwetha Kamath ¹

Cited by CrossRef: 46

1- Momenzadeh Abardeh Z, Bahrami F, Oganov A. Predicting co-crystal structures of N-halide phthalimides with 3,5-dimethylpyridine. Acta Crystallogr B Struct Sci Cryst Eng Mater. 2024;80(6):620 [Crossref]

2- Sawatdee S, Atipairin A, Rakkummerd S, Suriyaphol O, Harding D, Muenraya P, Harding P. Preparation and physicochemical characterization of sildenafil cocrystals. 2021;12(4):408 [Crossref]

3- Liu L, Wang J, Mei X. Enhancing the stability of active pharmaceutical ingredients by the cocrystal strategy. CrystEngComm. 2022;24(11):2002 [Crossref]

4- Haghighizadeh A, Mahdavi H, Rajabi O. Recent Progress in Antisolvent Crystallization of Pharmaceuticals with a Focus on the Membrane‐Based Technologies. Chem Eng & Technol. 2024;47(5):750 [Crossref]

5- Birolo R, Bravetti F, Bordignon S, D’Abbrunzo I, Mazzeo P, Perissutti B, Bacchi A, Chierotti M, Gobetto R. Overcoming the Drawbacks of Sulpiride by Means of New Crystal Forms. Pharmaceutics. 2022;14(9):1754 [Crossref]

6- Chauhan V, Mardia R, Patel M, Suhagia B, Parmar K. Technical and Formulation Aspects of Pharmaceutical Co‐Crystallization: A Systematic Review. ChemistrySelect. 2022;7(37) [Crossref]

7- Veith H, Zaeh M, Luebbert C, Rodríguez-Hornedo N, Sadowski G. Stability of Pharmaceutical Co-Crystals at Humid Conditions Can Be Predicted. Pharmaceutics. 2021;13(3):433 [Crossref]

8- Su H, Liu S, Fujii M, Sugimoto H, Tanaka Y, Sugiyama T. Optical trapping-induced crystallization promoted by gold and silicon nanoparticles. Photochem Photobiol Sci. 2024;23(9):1697 [Crossref]

9- SARAF G, BURADE K, GONJARI I, HOSMANI A, PAWAR A. A REVIEW ON ADVANCES IN PHARMACEUTICAL CO-CRYSTAL PREPARATION ROUTES, INTELLECTUAL PROPERTY PERSPECTIVE AND REGULATORY ASPECTS. Int J Curr Pharm Sci. 2022;:4 [Crossref]

10- Darusman F, Fakih T, Nurfarida G. Identification of the Glimepiride and Metformin Hydrochloride Physical Interaction in Binary Systems. Borneo J Pharm. 2021;4(2):110 [Crossref]

11- Rathi R, Kushwaha R, Goyal A, Singh I. Oxaliplatin-Flavone Pharmaceutical Co-Crystal-CN111205332A: Patent Spotlight. Pharm Pat Anal. 2022;11(5):147 [Crossref]

12- Yadav D, Savjani J, Savjani K, Shah H. Exploring Potential Coformer Screening Techniques Based on Experimental and Virtual Strategies in the Manufacturing of Pharmaceutical Cocrystal of Efavirenz. J Pharm Innov. 2023; [Crossref]

13- Luján-Torres V, Gutiérrez-Méndez N, Carballo-Carballo D, Leal-Ramos M, Salmerón I, Pérez-Vega S, Martínez-Monteagudo S. Co-crystallization of lactose-flavonoids using Panela cheese whey. Journal of Food Engineering. 2023;357:111598 [Crossref]

14- Sharma P, Gomila R, Frontera A, Barcelo-Oliver M, Bhattacharyya M. Dicarboxylic Acid-Based Co-Crystals of Pyridine Derivatives Involving Structure Guiding Unconventional Synthons: Experimental and Theoretical Studies. Crystals. 2022;12(10):1442 [Crossref]

15- Muthusamy A, Singh A, Sundaram M, Wagh Y, Jegorov A, Jain A. In-Silico Aided Screening and Characterization Results in Stability Enhanced Novel Roxadustat Co-Crystal. Journal of Pharmaceutical Sciences. 2024;113(5):1190 [Crossref]

16- Wang W, Okano K, Yoshikawa H, Sugiyama T. Optical Trapping Controlled Cocrystallization Dynamics of Acetaminophen and l-Phenylalanine. Crystal Growth & Design. 2024;24(14):6028 [Crossref]

17- Lou Y, Yu K, Wu X, Wang Z, Cui Y, Bao H, Wang J, Hu X, Ji Y, Tang G. Co-Crystals of Resveratrol and Polydatin with L-Proline: Crystal Structures, Dissolution Properties, and In Vitro Cytotoxicities. Molecules. 2021;26(18):5722 [Crossref]

18- Castiello C, Junghanns P, Mergel A, Jacob C, Ducho C, Valente S, Rotili D, Fioravanti R, Zwergel C, Mai A. GreenMedChem: the challenge in the next decade toward eco-friendly compounds and processes in drug design. Green Chem. 2023;25(6):2109 [Crossref]

19- A, I, N, S. Pharmaceutical cocrystal and their role in improving solid state properties of active pharmaceutical ingredients. AJPS. 2023;23(2):180 [Crossref]

20- Abdelaziz A, Tarchoun A, Boukeciat H, Trache D. Insight into the Thermodynamic Properties of Promising Energetic HNTO·AN Co-Crystal: Heat Capacity, Combustion Energy, and Formation Enthalpy. Energies. 2022;15(18):6722 [Crossref]

21- Herrmannsdörfer D, Klapötke T. Semibatch Reaction Crystallization for Scaled-Up Production of High-Quality CL-20/HMX Cocrystal: Efficient Because of Solid Dosing. Crystal Growth & Design. 2021;21(3):1708 [Crossref]

22- Trzeciak K, Wielgus E, Kaźmierski S, Pawlak T, Potrzebowski M. Amorphization of Ethenzamide and Ethenzamide Cocrystals—A Case Study of Single and Binary Systems Forming Low-Melting Eutectic Phases Loaded on/in Silica Gel. Pharmaceutics. 2023;15(4):1234 [Crossref]

23- Xiong J, Xu D, Zhang H, Shi Y, Wu X, Wang S. Improving the Solubility and Bioavailability of Progesterone Cocrystals with Selected Carboxylic Acids. Pharmaceutics. 2024;16(6):816 [Crossref]

24- Zhao J, Zhang Q, Yan Y, Xue Y, Zhang X. Phase diagram and nucleation kinetics of barbituric acid – Urea Co-crystal: Focus on metastable zone width and activation energy. Journal of Molecular Liquids. 2023;385:122305 [Crossref]

25- Garg U, Azim Y. Challenges and opportunities of pharmaceutical cocrystals: a focused review on non-steroidal anti-inflammatory drugs. RSC Med Chem. 2021;12(5):705 [Crossref]

26- Ding Y, Zhao T, Fang J, Song J, Dong H, Liu J, Li S, Zhao M. Recent developments in the use of nanocrystals to improve bioavailability of APIs. WIREs Nanomed Nanobiotechnol. 2024;16(2) [Crossref]

27- Zhang S, Zhang X, Meng J, Lu L, Du S, Xu H, Wu S. Study on the Effect of Polymer Excipients on the Dispersibility, Interaction, Solubility, and Scavenging Reactive Oxygen Species of Myricetin Solid Dispersion: Experiment and Molecular Simulation. ACS Omega. 2022;7(1):1514 [Crossref]

28- Shano L, Karthikeyan S, Kennedy L, Chinnathambi S, Pandian G. MOFs for next-generation cancer therapeutics through a biophysical approach—a review. Front Bioeng Biotechnol. 2024;12 [Crossref]

29- Shemchuk O, Spoletti E, Braga D, Grepioni F. Solvent Effect on the Preparation of Ionic Cocrystals of dl-Amino Acids with Lithium Chloride: Conglomerate versus Racemate Formation. Crystal Growth & Design. 2021;21(6):3438 [Crossref]

30- Jubeen F, Jabeen I, Aftab U, Noor S, Hareem M, Sultan M, Kazi M. Synthesis, Characterization, Theoretical and Experimental Anticancer Evaluation of Novel Cocrystals of 5-Fluorouracil and Schiff Bases against SW480 Colorectal Carcinoma. Pharmaceutics. 2023;15(7):1929 [Crossref]

31- Giri L, Rout S, Kar A, Kenguva G, Dandela R. Pharmaceutical novel solid forms of Milrinone with advanced physicochemical properties. Journal of Molecular Structure. 2022;1269:133746 [Crossref]

32- Sharma A, Katta C, Bahuguna D, Veerabomma H, Mourya A, Jyothi V, Dikundwar A, Singh S, Madan J. Voriconazole-syringic acid co-crystals reduced voriconazole-induced hepatotoxicity: In vitro and in vivo studies. Journal of Drug Delivery Science and Technology. 2023;86:104685 [Crossref]

33- Zhou Y, Tu Y, Yang J, Qian K, Liu X, Fu Q, Xu X, Chen S. Enhancing the Stability, Solubility, and Antioxidant Activity of Cinchonine through Pharmaceutical Cocrystallization. Pharm Res. 2024;41(6):1257 [Crossref]

34- Ranguelov B, Nanev C. 2D Monte Carlo Simulation of Cocrystal Formation Using Patchy Particles. Crystals. 2022;12(10):1457 [Crossref]

35- J T, NN S, Raheem T A, SKK S, G T. Modafinil Cocrystals for Altered Physicochemical Properties. RJPT. 2021;:4891 [Crossref]

36- Alatas F, Stiawan D, Al-Hakim N. Solubility and Scale-Up Potency of Norfloxacin-Urea Co-Crystal Prepared by Ultrasound-Assisted Slurry Co-Crystallization Method. Borneo J Pharm. 2023;6(2):158 [Crossref]

37- Madanayake S, Manipura A, Thakuria R, Adassooriya N. Opportunities and Challenges in Mechanochemical Cocrystallization toward Scaled-Up Pharmaceutical Manufacturing. Org Process Res Dev. 2023;27(3):409 [Crossref]

38- Kumbhar P, Kolekar K, Khot C, Dabhole S, Salawi A, Sabei F, Mohite A, Kole K, Mhatre S, Jha N, Manjappa A, Singh S, Dua K, Disouza J, Patravale V. Co-crystal nanoarchitectonics as an emerging strategy in attenuating cancer: Fundamentals and applications. Journal of Controlled Release. 2023;353:1150 [Crossref]

39- Lu Z, Chen H, Mo J, Yuan X, Wang D, Zheng X, Zhu W. Cocrystal of phloretin with isoniazid: preparation, characterization, and evaluation. RSC Adv. 2023;13(16):10914 [Crossref]

40- Gołdyn M, Larowska D, Bartoszak-Adamska E. Novel Purine Alkaloid Cocrystals with Trimesic and Hemimellitic Acids as Coformers: Synthetic Approach and Supramolecular Analysis. Crystal Growth & Design. 2021;21(1):396 [Crossref]

41- Poka M, Milne M, Wessels A, Aucamp M. Sugars and Polyols of Natural Origin as Carriers for Solubility and Dissolution Enhancement. Pharmaceutics. 2023;15(11):2557 [Crossref]

42- Abeysekera A, Sinha A, Aakeroy C. The Impact of Halogen Substituents on the Synthesis and Structure of Co-Crystals of Pyridine Amides. Molecules. 2021;26(4):1147 [Crossref]

43- Elshaer M, Osman S, Mohammed A, Zayed G. Co-crystallization of Hesperidin with different co-formers to enhance solubility, antioxidant and anti-inflammatory activities. Pharmaceutical Development and Technology. 2024;29(7):691 [Crossref]